Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Saamya Biotech IPO.
April 23, 2024 7:30:15 PM
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Published by : CNBC on MSNMarch 15, 2024 9:37:00 AM
While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.
Published by : The UBJ on MSNMarch 29, 2024 3:30:00 AM
It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesApril 5, 2024 10:30:00 AM
Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...
Published by : FierceBiotechMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 11, 2024 12:30:00 PM
its intersecting role in the biotech sector has been a boon for industry � making biotech IPOs more coveted this year. Klarna European fintech darling Klarna was once the continent's highest ...
Published by : Business InsiderApril 12, 2024 3:30:00 AM
The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter last year, and roughly matches the first quarter total in 2020. Six of the nine biotechs ...
Published by : Yahoo FinanceApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceApril 1, 2024 3:30:00 AM
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we learn about how scientists had a happenstance ...
Published by : STATMarch 30, 2024 9:30:00 AM
Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted ...
Published by : Seeking AlphaMarch 21, 2024 6:34:00 PM
Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...
Published by : Benzinga.comApril 10, 2024 11:07:00 AM
It�ll begin trading on the Nasdaq stock exchange on Friday under the symbol �CTNM.� Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By ...
Published by : Yahoo FinanzasIPO Allotment Status is now available online for Saamya Biotech India Limited.
Saamya Biotech India Limited IPO was closed on September 28, 2007.
Saamya Biotech India Limited IPO listing info:
IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share
Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.
SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).
The Saamya Biotech IPO is proposed to open on September 25, 2007. The IPO application ends on September 28, 2007.
Retail investors can apply in the retail or non-institutional investor category from September 25, 2007 to September 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Saamya Biotech IPO will open for subscription on September 25, 2007. The public issue will close on September 28, 2007.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
DRHP
